Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma.

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Chromatography B Pubmed

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma.

Journal of Chromatography B , Volume 1105: 9 – Feb 11, 2019
Loading next page...
 
/lp/pubmed/development-and-validation-of-an-uplc-ms-ms-bioanalytical-method-for-J8ussVYYJi

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2018 Elsevier B.V. All rights reserved.
ISSN
1570-0232
eISSN
1873-376X
DOI
10.1016/j.jchromb.2018.12.008
pmid
30572204

Abstract

Journal

Journal of Chromatography BPubmed

Published: Feb 11, 2019

There are no references for this article.